JOSE PARRA: Open Payments
NPI 1740725506 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,936 in 123 payments from 15 companies in 2025. Trend: 2023 $2,454 · 2024 $2,346 · 2025 $2,936
Food & beverage: $2,737Education: $199
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $519 |
| Teva Pharmaceuticals USA, Inc. | 14 | $429 |
| Neurocrine BioSciences, Inc. | 11 | $317 |
| ABBVIE INC. | 21 | $278 |
| Janssen Pharmaceuticals, Inc | 7 | $273 |
| Otsuka America Pharmaceutical, Inc. | 11 | $255 |
| E.R. Squibb & Sons, L.L.C. | 14 | $240 |
| Alkermes, Inc. | 10 | $136 |
| Gilead Sciences, Inc. | 1 | $122 |
| ViiV Healthcare Company | 3 | $116 |
Products named: CAPLYTA, INGREZZA, COBENFY, INVEGA SUSTENNA, VRAYLAR, ABILIFY MAINTENA, UZEDY, Yeztugo.
Industry payments across OH — which companies pay providers there.
